(1st treatment: total 6 times, every weeks) Day 1: Select peptide candidates (up to 4), to which peptide-specific IgGs are detected before vaccination, and administer peptides that showed the highe
Sponsors
Kurume University Cancer Vaccine Center, Kurume University School of medicine, Department of Immunology
Conditions
Biliary cancer (Cholangiocell carcinoma,Gallbladder cancer and Biliary tract cancer)Hepatocellular carcinomaPancreatic cancerProstate cancerRenal cell carcinomaScirrhous gastric cancerUrotherial cancerbreast cancer
Phase 2
Phase II clinical trial of personalized peptide vaccination for advanced breast cancer
Active, not recruitingJPRN-UMIN000001844
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for primary lung cancer
Active, not recruitingJPRN-UMIN000001839
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for refractory cervical cancer patients
Active, not recruitingJPRN-UMIN000001847
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for ovarian cancer patients
Active, not recruitingJPRN-UMIN000001856
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic renal cell carcinoma failed to standard treatment
Active, not recruitingJPRN-UMIN000001855
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for hormone refractory prostate cancer patients
Active, not recruitingJPRN-UMIN000001850
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination in patients with advanced/metastatic urotherial cancer failed to standard treatment
Active, not recruitingJPRN-UMIN000001854
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for malignant brain tumor patients
Active, not recruitingJPRN-UMIN000001875
Start: 2009-04-01Target: 60Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for standard therapy failed or unoperable Pancreatic cancer patients
Active, not recruitingJPRN-UMIN000001881
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for standard chemotherapy failed scirrhous gastric cancer patients
Active, not recruitingJPRN-UMIN000001883
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for standard therapy failed Hepatocellular carcinoma patients
Active, not recruitingJPRN-UMIN000001882
Start: 2009-04-01Target: 100Updated: 2026-06-29
Phase II clinical trial of personalized peptide vaccination for standard therapy failed Biliary cancer(Cholangiocell carcinoma,Gallbladder cancer and Biliary tract cancer) patients
Active, not recruitingJPRN-UMIN000001884
Start: 2009-04-01Target: 100Updated: 2026-06-29